Definition
The cathepsins are lysosomal proteases that are ubiquitously expressed. Cathepsin S is a cysteine protease that displays tissue-specific distribution in antigen-presenting cells (APCs). Cathepsin S (CatS) is critically involved in the process of antigen presentation and is therefore essential for host immune function. Secretion of CatS by spinal microglia contributes to enhanced nociceptive transmission in rodent models of peripheral nerve injury. Microglia are cells abundant in CNS parenchyma which belong to the myelomonocytic lineage also including monocytes and macrophages. Quiescent microglia perform immune surveillance of the nervous system by elaborate branch structures which rarely overlap with nearby microglia cells. Microglia are rapidly activated by direct insults to the central nervous system (CNS), but they also react...
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andrei, C., Margiocco, P., Poggi, A., Lotti, L. V., Torrisi, M. R., & Rubartelli, A. (2004). From the cover: Phospholipases C and A2 control lysosome-mediated IL-1{beta} secretion: Implications for inflammatory processes. PNAS, 101, 9745–9750.
Bajetto, A., Bonavia, R., Barbero, S., & Schettini, G. (2002). Characterization of chemokines and their receptors in the central nervous system: Physiopathological implications. Journal of Neurochemistry, 82, 1311–1329.
Barclay, J., Clark, A. K., Ganju, P., Gentry, C., Patel, S., Wotherspoon, G., Buxton, F., Song, C., Ullah, J., Winter, J., Fox, A., Bevan, S., & Malcangio, M. (2007). Role of the cysteine protease cathepsin S in neuropathic hyperalgesia. Pain, 130, 225–234.
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997). A new class of membrane-bound chemokine with a CX3C motif. Nature, 385, 640–644.
Beers, C., Burich, A., Kleijmeer, M. J., Griffith, J. M., Wong, P., & Rudensky, A. Y. (2005). Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo. Journal of Immunology, 174, 1205–1212.
Boya, P., & Kroemer, G. (2008). Lysosomal membrane permeabilization in cell death. Oncogene, 27, 6434–6451.
Brzin, J., Popovic, T., Turk, V., Borchart, U., & Machleidt, W. (1984). Human cystatin, a new protein inhibitor of cysteine proteinases. Biochemical and Biophysical Research Communications, 118, 103–109.
Clark, A. K., D’Aquisto, F., Gentry, C., Marchand, F., McMahon, S. B., & Malcangio, M. (2006). Rapid co-release of interleukin 1beta and caspase 1 in spinal cord inflammation. Journal of Neurochemistry, 99, 868–880.
Clark, A. K., Yip, P. K., Grist, J., Gentry, C., Staniland, A. A., Marchand, F., Dehvari, M., Wotherspoon, G., Winter, J., Ullah, J., Bevan, S., & Malcangio, M. (2007). Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proceedings of the National Academy of Sciences of the United States of America, 104, 10655–10660.
Clark, A. K., Yip, P. K., & Malcangio, M. (2009). The liberation of fractalkine in the dorsal horn requires microglial cathepsin S. Journal of Neuroscience, 29, 6945–6954.
Clark, A. K., Wodarski, R., Guida, F., Sasso, O., & Malcangio, M. (2010a). Cathepsin S release from primary cultured microglia is regulated by the P2X7 receptor. Glia, 58, 1710–1726.
Clark, A. K., Staniland, A. A., Marchand, F., Kaan, T. K. Y., McMahon, S. B., & Malcangio, M. (2010b). P2X7-Dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide. Journal of Neuroscience, 30, 573–582.
Clark, A. K., Marchand, F., D’Auria, M., Davies, M., Grist, J., Malcangio, M., & McMahon, S. B. (2010c). Cathepsin S inhibiton attenuates neuropathic pain and microglial response associated with spinal cord injury. The Open Pain Journal, 3, 117–122.
Clark, A. K., Grist, J., Al-Kashi, A., Perretti, M., & Malcangio, M. (2012). Microglial Cathepsin S and CX3CR1 contribute to chronic pain in collagen induced arthritis. Arthritis and Rheumatism, 64, 2038–2047.
Cole, T., Dickson, P. W., Esnard, F., Averill, S., Risbridger, G. P., Gauthier, F., & Schreiber, G. (1989). The cDNA structure and expression analysis of the genes for the cysteine proteinase inhibitor cystatin C and for beta2-microglobulin in rat brain. European Journal of Biochemistry, 186, 35–42.
Costigan, M., Befort, K., Karchewski, L., Griffin, R. S., D’Urso, D., Allchorne, A., Sitarski, J., Mannion, J. W., Pratt, R. E., & Woolf, C. J. (2002). Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury. BMC Neuroscience, 16, 16.
Coulombe, R., Grochulski, P., Sivaraman, J., Menard, R., Mort, J. S., & Cygler, M. (1996). Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO Journal, 15, 5492–5503.
Cuozzo, J. W., Tao, K., Ql, W., Young, W., & Sahagian, G. G. (1995). Lysine-based structure in the proregion of procathepsin L is the recognition site for mannose phosphorylation. Journal of Biological Chemistry, 270, 15611–15619.
Dalrymple, S. A, Grist, J., Clark, A. K., & Malcangio, M. (2009). Systemic inhibition of cathepsin S attenuates vincristine-induced neuropathic hypersensitivity.
Di Virgilio, F. (2007). Liaisons dangereuses: P2X7 and the inflammasome. Trends in Pharmacological Sciences, 28, 465–472.
Driessen, C., Bryant, R. A. R., Lennon-Dumenil, A. M., Villadangos, J. A., Bryant, P. W., Shi, G. P., Chapman, H. A., & Ploegh, H. L. (1999). Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. The Journal of Cell Biology, 147, 775–790.
Eisenach, J. C., Thomas, J. A., Rauck, R. L., Curry, R., & Li, X. (2004). Cystatin C in cerebrospinal fluid is not a diagnostic test for pain in humans. Pain, 107, 207–212.
Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E., & Di Virgilio, F. (2006). The P2X7 receptor: A key player in IL-1 processing and release. Journal of Immunology, 176, 3877–3883.
Ghosh, P., Amaya, M., Mellins, E., & Wiley, D. C. (1995). The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature, 378, 457–462.
Gresser, O., Weber, E., Hellwig, A., Riese, S., & Regnier-Vigouroux, A. (2001). Immunocompetent astrocytes and microglia display major differences in the processing of the invariant chain and in the expression of active cathepsin L and cathepsin S. European Journal of Immunology, 31, 1813–1824.
Gutmann, H. R., & Fruton, J. S. (1948). On the proteolytic enzymes of animal tissues VIII. An intracellular enzyme related to chymotrypsin. Journal of Biological Chemistry, 174, 851–858.
Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., Botti, P., Bacon, K. B., & Feng, L. (1998). Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. PNAS, 95, 10896–10901.
Holmes, F. E., Arnott, N., Vanderplank, P., Kerr, N. C., Longbrake, E. E., Popovich, P. G., Imai, T., Combadiere, C., Murphy, P. M., & Wynick, D. (2008). Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour. Journal of Neurochemistry, 106, 640–649.
Holsinger, L. I., Grist, J., Clark, A. K., Booth, R., Malcangio, M., & Dalrymple, S. A. (2010). Systemic inhibition of cathepsin S attenuates hypersensitivity in animal models of neuropathic and inflammatory pain.
Hughes, P. M., Botham, M. S., Frentzel, S., Mir, A., & Perry, V. H. (2002). Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia, 37, 314–327.
Inoue, K., & Tsuda, M. (2009). Microglia and neuropathic pain. Glia, 57, 1469–1479.
Irie, O., et al. (2008). Discovery of orally bioavailable cathepsin S inhibitors for the reversal of neuropathic pain. Journal of Medicinal Chemistry, 51, 5502–5505.
Ishidoh, K., Muno, D., Sato, N., & Kominami, E. (1991). Molecular cloning of cDNA for rat cathepsin C. Cathepsin C, a cysteine proteinase with an extremely long propeptide. Journal of Biological Chemistry, 266, 16312–16317.
Jin, S. X., Zhuang, Z. Y., Woolf, C. J., & Ji, R. R. (2003). p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. Journal of Neuroscience, 23, 4017–4022.
Kominami, E., Tsukahara, T., Hara, K., & Katunuma, N. (1988). Biosyntheses and processing of lysosomal cysteine proteinases in rat macrophages. FEBS Letters, 231, 225–228.
Kubo, T., Yamashita, T., Yamaguchi, A., Hosokawa, K., & Tohyama, M. (2002). Analysis of genes induced in peripheral nerve after axotomy using cDNA microarrays. Journal of Neurochemistry, 82, 1129–1136.
Levine, J. D., & Reichling, D. B. (1999). Peripheral mechanisms of inflammatory pain. In P. D. Wall & R. Melzack (Eds.), Texbook of pain (pp. 59–84). Livingstone: Churchill.
Lindia, J. A., McGowan, E., Jochnowitz, N., & Abbadie, C. (2005). Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. The Journal of Pain, 6, 434–438.
Liuzzo, J. P., Petanceska, S. S., & Devi, L. A. (1999a). Neurotrophic factors regulate cathepsin S in macrophages and microglia: A role in the degradation of myelin basic protein and amyloid beta peptide. Molecular Medicine, 5, 334–343.
Liuzzo, J. P., Petanceska, S. S., Moscatelli, D., & Devi, L. A. (1999b). Inflammatory mediators regulate cathepsin S in macrophages and microglia: A role in attenuating heparan sulfate interactions. Molecular Medicine, 5, 320–333.
Lopez-Castejon, G., Theaker, J., Pelegrin, P., Clifton, A. D., Braddock, M., & Surprenant, A. (2010). P2X(7) receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases. Journal of Immunology, 185, 2611–2619.
Mannes, A. J., Martin, B. M., Yang, H. Y., Keller, J. M., Lewin, S., Gaiser, R. R., & Iadarola, M. J. (2003). Cystatin C as a cerebrospinal fluid biomarker for pain in humans. Pain, 102, 251–256.
Mason, R. W., Gal, S., & Gottesman, M. M. (1987). The identification of the major excreted protein (MEP) from a transformed mouse fibroblast cell line as a catalytically active precursor form of cathepsin L. Biochemical Journal, 248, 449–454.
McMahon, S. B., & Malcangio, M. (2009). Current challenges in glia-pain biology. Neuron, 64, 46–54.
Milligan, E. D., Zapata, V., Chacur, M., Schoeniger, D., Biedenkapp, J., O’Connor, K. A., Verge, G. M., Chapman, G., Green, P., Foster, A. C., Naeve, G. S., Maier, S. F., & Watkins, L. R. (2004). Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. European Journal of Neuroscience, 20, 2294–2302.
Milligan, E., Zapata, V., Schoeniger, D., Chacur, M., Green, P., Poole, S., Martin, D., Maier, S. F., & Watkins, L. R. (2005). An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine. European Journal of Neuroscience, 22, 2775–2782.
Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000). International union of pharmacology XXII. Nomenclature for chemokine receptors. Pharmacology Review, 52, 145–176.
Nakagawa, T. Y., Brissette, W. H., Lira, P. D., Griffiths, R. J., Petrushova, N., Stock, J., McNeish, J. D., Eastman, S. E., Howard, E. D., & Clarke, S. R. M. (1999). Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity, 10, 207–217.
Nishiyori, A., Minami, M., Ohtani, Y., Takami, S., Yamamoto, J., Kawaguchi, N., Kume, T., Akaike, A., & Satoh, M. (1998). Localization of fractalkine and CX3CR1 mRNAs in rat brain: Does fractalkine play a role in signaling from neuron to microglia? FEBS Letters, 429, 167–172.
Pan, Y., Lloyd, C., Zhou, H., Dolich, S., Deeds, J., Gonzalo, J. A., Vath, J., Gosselin, M., Ma, J., Dussault, B., Woolf, E., Alperin, G., Culpepper, J., Gutierrez-Ramos, J. C., & Gearing, D. (1997). Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature, 387, 611–617.
Petanceska, S., & Devi, L. (1992). Sequence analysis, tissue distribution, and expression of rat cathepsin S. Journal of Biological Chemistry, 267, 26038–26043.
Petanceska, S., Burke, S., Watson, S. J., & Devi, L. (1994). Differential distribution of messenger RNAs for cathepsins B, L and S in adult rat brain: An in situ hybridization study. Neuroscience, 59, 729–738.
Petanceska, S., Canoll, P., & Devi, L. A. (1996). Expression of rat cathepsin S in phagocytic cells. Journal of Biological Chemistry, 271, 4403–4409.
Pierre, P., & Mellman, I. (1998). Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell, 93, 1135–1145.
Podobnik, M., Kuhelj, R., Turk, V., & Turk, D. (1997). Crystal structure of the wild-type human procathepsin B at 2.5 A resolution reveals the native active site of a papain-like cysteine protease zymogen. Journal of Molecular Biology, 271, 774–788.
Riese, R. J., Wolf, P. R., Bromme, D., Natkin, L. R., Villadangos, J. A., Ploegh, H. L., & Chapman, H. A. (1996). Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity, 4, 357–366.
Riese, R. J., Mitchell, R. N., Villadangos, J. A., Shi, G. P., Palmer, J. T., Karp, E. R., De Sanctis, G. T., Ploegh, H. L., & Chapman, H. A. (1998). Cathepsin S activity regulates antigen presentation and immunity. The Journal of Clinical Investigation, 101, 2351–2363.
Ritonja, A., Colic, A., Dolenc, I., Ogrinc, T., Podobnik, M., & Turk, V. (1991). The complete amino acid sequence of bovine cathepsin S and a partial sequence of bovine cathepsin L. FEBS Letters, 283, 329–331.
Rowan, A. D., Mason, P., Mach, L., & Mort, J. S. (1992). Rat procathepsin B. Proteolytic processing to the mature form in vitro. Journal of Biological Chemistry, 267, 15993–15999.
Rozman, J., Stojan, J., Kuhelj, R., Turk, V., & Turk, B. (1999). Autocatalytic processing of recombinant human procathepsin B is a bimolecular process. FEBS Letters, 459, 358–362.
Schwaeble, W. J., Stover, C. M., Schall, T. J., Dairaghi, D. J., Trinder, P. K. E., Linington, C., Iglesias, A., Schubart, A., Lynch, N. J., Weihe, E., & Schafer, M. K. (1998). Neuronal expression of fractalkine in the presence and absence of inflammation. FEBS Letters, 439, 203–207.
Schwarz, G., Boehncke, W. H., Braun, M., Schroter, C. J., Burster, T., Flad, T., Dressel, D., Weber, E., Schmid, H., & Kalbacher, H. (2002). Cathepsin S activity is detectable in human keratinocytes and is selectively upregulated upon stimulation with interferon-gamma. The Journal of Investigative Dermatology, 119, 44–49.
Shi, G. P., Munger, J. S., Meara, J. P., Rich, D. H., & Chapman, H. A. (1992). Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. Journal of Biological Chemistry, 267, 7258–7262.
Shi, G. P., Villadangos, J. A., Dranoff, G., Small, C., Gu, L., Haley, K. J., Riese, R., Ploegh, H. L., & Chapman, H. A. (1999). Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity, 10, 197–206.
Staniland, A. A., Clark, A. K., Wodarski, R., Sasso, O., Maione, F., D’Acquisto, F., & Malcangio, M. (2010). Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice. Journal of Neurochemistry, 114, 1143–1157.
Takio, K., Towatari, T., Katunuma, N., Teller, D. C., & Titani, K. (1983). Homology of amino acid sequences of rat liver cathepsins B and H with that of papain. PNAS, 80, 3666–3670.
Tao, K., Stearns, N. A., Dong, J. M., Wu, Q. L., & Sahagian, G. G. (1994). The proregion of cathepsin L is required for proper folding, stability, and ER exit. Archives of Biochemistry and Biophysics, 311, 19–27.
Tsuda, M., Mizokoshi, A., Shigemoto-Mogami, Y., Koizumi, S., & Inoue, K. (2004). Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia, 45, 89–95.
Turk, B., Dolenc, I., Lenarcic, B., Krizaj, I., Turk, V., Bieth, J. G., & Bjork, I. (1999). Acidic pH as a physiological regulator of human cathepsin L activity. European Journal of Biochemistry, 259, 926–932.
Turnsek, T., Kregar, I., & Lebez, D. (1975). Acid sulphydryl protease from calf lymph nodes. Biochimica et Biophysica Acta (BBA) Enzymology, 403, 514–520.
Valder, C. R., Liu, J. J., Song, Y. H., & Luo, Z. D. (2003). Coupling gene chip analyses and rat genetic variances in identifying potential target genes that may contribute to neuropathic allodynia development. Journal of Neurochemistry, 87, 560–573.
Vasiljeva, O., Dolinar, M., Pungercar, J. R., Turk, V., & Turk, B. (2005). Recombinant human procathepsin S is capable of autocatalytic processing at neutral pH in the presence of glycosaminoglycans. FEBS Letters, 579, 1285–1290.
Verge, G. M., Milligan, E. D., Maier, S. F., Watkins, L. R., Naeve, G. S., & Foster, A. C. (2004). Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. European Journal of Neuroscience, 20, 1150–1160.
Villadangos, J. A., Riese, R. J., Peters, C., Chapman, H. A., & Ploegh, H. L. (1997). Degradation of mouse invariant chain: Roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. The Journal of Experimental Medicine, 186, 549–560.
Wada, K., Takai, T., & Tanabe, T. (1987). Amino acid sequence of chicken liver cathepsin L. European Journal of Biochemistry, 167, 13–18.
Wiederanders, B., Broemme, D., Kirschke, H., Kalkkinen, N., Rinne, A., Paquette, T., & Toothman, P. (1991). Primary structure of bovine cathepsin S comparison to cathepsins L, H, B and papain. FEBS Letters, 286, 189–192.
Zhuang, Z. Y., Kawasaki, Y., Tan, P. H., Wen, Y. R., Huang, J., & Ji, R. R. (2007). Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain, Behavior, and Immunity, 21, 642–651.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Clark, A.K., Ogbonna, A.C., Malcangio, M. (2013). Cathepsin and Microglia. In: Gebhart, G.F., Schmidt, R.F. (eds) Encyclopedia of Pain. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-28753-4_4922
Download citation
DOI: https://doi.org/10.1007/978-3-642-28753-4_4922
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-28752-7
Online ISBN: 978-3-642-28753-4
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences